This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its structure, featuring both dimethylamino and methoxyphenyl groups, makes it valuable in the development of drugs targeting neurological and cardiovascular systems. The compound’s chiral nature, combined with the succinate moiety, enhances its ability to interact with specific biological receptors, improving drug efficacy and selectivity. It is often employed in the production of medications designed to modulate neurotransmitter activity or as a precursor in the creation of antihypertensive and antiarrhythmic drugs. Additionally, its stability and solubility properties make it suitable for formulation into oral or injectable dosage forms.